Well, CTIC picked up a not so good JAK2/FLT3 drug ONXX discarded. Surprised BioWorld had a lengthy article on it today. I suppose they at least discussed with FDA/EMA on ph3 trial design for MF. It doesn't mean they can carry out the plan as planned though :-).
Market Data 
Markets 
AI
